Gossamer Bio (GOSS) Net Margin (2024 - 2026)
Gossamer Bio (GOSS) posted quarterly Net Margin of 295.38% for Q1 2026, up 10165.0% year-over-year from N/an in Q1 2025, and up 13.71% quarter-over-quarter from 342.33% in Q4 2025.
Gossamer Bio (GOSS) Net Margin (2024 - 2026) Analysis & Trends
Gossamer Bio's Net Margin history runs 3 years deep, the most recent figure standing at 295.38% for Q1 2026.
- In Q1 2026, Net Margin rose 10165.0% year-over-year to 295.38%; the TTM figure through Mar 2026 stood at 330.98% (down 27743.0% YoY), while the FY2025 annual figure was 351.49%, down 28916.0% from the prior year.
- Net Margin for Q1 2026 stood at 295.38%, up from 342.33% in the prior quarter.
- The five-year high for Net Margin was 225.89% in Q4 2024, with the low at 397.03% in Q1 2025.
- The 3-year median for Net Margin is 329.2% (2024), against an average of 222.32%.
- The sharpest annual moves came in 2025 and 2026: Net Margin plunged 56821 bps in 2025, then surged 10165 bps in 2026.
- Gossamer Bio's Net Margin stood at 225.89% in 2024, then plunged by 252 bps to 342.33% in 2025, then rose by 14 bps to 295.38% in 2026.
- Business Quant data shows GOSS's Net Margin at 295.38% in Q1 2026, 342.33% in Q4 2025, and 362.73% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.22 Bn | 132.37 Bn | 2.84 Bn | 32.99% |
| 2 | Regeneron Pharmaceuticals | 86.29 Bn | 78.30 Bn | 3.93 Bn | 30.23% |
| 3 | Argenx Se | 65.17 Bn | 59.98 Bn | 1.37 Bn | 31.16% |
| 4 | Moderna | 61.38 Bn | 56.24 Bn | 52.00 Mn | -539.31% |
| 5 | BeOne Medicines | 42.18 Bn | 37.09 Bn | 1.53 Bn | 13.90% |
| 6 | Alnylam Pharmaceuticals | 30.99 Bn | 27.68 Bn | 992.69 Mn | 12.74% |
| 7 | BioNTech SE | 28.45 Bn | 10.05 Bn | 668.28 Mn | -16.51% |
| 8 | Insmed | 27.47 Bn | 26.31 Bn | 358.27 Mn | -3.12% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 12.09% |
| 10 | Gossamer Bio | 47.81 Mn | -9.22 Mn | - | -308.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -331.08% |
| Mar 31, 2026 | -295.38% |
| Dec 31, 2025 | -342.33% |
| Sep 30, 2025 | -362.73% |
| Jun 30, 2025 | -333.13% |
| Mar 31, 2025 | -397.03% |
| Dec 31, 2024 | 225.89% |
| Sep 30, 2024 | -325.26% |
| Jun 30, 2024 | 51.40% |